A synthetic peptide for use as a blocking control in assays to test for specificity of SET antibody, Alternative Names: SET control peptide, SET antibody Blocking Peptide, Anti-SET Blocking Peptide, Set Nuclear Oncogene Blocking Peptide, 2PP2A Blocking Peptide, I2PP2A Blocking Peptide, IGAAD Blocking Peptide, PHAPII Blocking Peptide, TAF-IBETA Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Synonyme
2PP2A Peptide, I2PP2A Peptide, IGAAD Peptide, IPP2A2 Peptide, PHAPII Peptide, TAF-I Peptide, TAF-IBETA Peptide, 2610030F17Rik Peptide, 5730420M11Rik Peptide, AA407739 Peptide, I-2PP2A Peptide, StF-IT-1 Peptide, 2pp2a Peptide, i2pp2a Peptide, igaad Peptide, ipp2a2 Peptide, phapii Peptide, set Peptide, set-a Peptide, set-b Peptide, taf-ibeta Peptide, wu:fb30g11 Peptide, wu:fd16c08 Peptide, SET nuclear proto-oncogene Peptide, SET nuclear oncogene Peptide, SET translocation Peptide, SET nuclear proto-oncogene L homeolog Peptide, SET nuclear proto-oncogene b Peptide, SET Peptide, Set Peptide, LOC403555 Peptide, set.L Peptide, setb Peptide
Hintergrund
SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1.